Jill Reckless

1.0k total citations
28 papers, 844 citations indexed

About

Jill Reckless is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Jill Reckless has authored 28 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Oncology and 6 papers in Genetics. Recurrent topics in Jill Reckless's work include Chemokine receptors and signaling (11 papers), Immunotherapy and Immune Responses (5 papers) and Cell Adhesion Molecules Research (5 papers). Jill Reckless is often cited by papers focused on Chemokine receptors and signaling (11 papers), Immunotherapy and Immune Responses (5 papers) and Cell Adhesion Molecules Research (5 papers). Jill Reckless collaborates with scholars based in United Kingdom, United States and Portugal. Jill Reckless's co-authors include David J. Grainger, Elaine McKilligin, James C. Metcalfe, Edward M. Rubin, John S. Beech, David Menon, Steven Williams, David J. Fox, David E. Mosedale and Stuart Warren and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Jill Reckless

26 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Reckless United Kingdom 15 326 250 154 129 129 28 844
Jens Gerwien Denmark 17 448 1.4× 295 1.2× 173 1.1× 57 0.4× 110 0.9× 33 1.1k
Cornelius A. Watson United States 8 316 1.0× 258 1.0× 103 0.7× 96 0.7× 82 0.6× 13 993
Dennis H. M. Kusters Netherlands 14 406 1.2× 633 2.5× 72 0.5× 111 0.9× 102 0.8× 18 1.1k
Mineko Tsuruoka Japan 6 482 1.5× 238 1.0× 215 1.4× 43 0.3× 72 0.6× 7 916
Kazuyoshi Watanabe Japan 14 349 1.1× 191 0.8× 135 0.9× 100 0.8× 65 0.5× 29 797
M. Sanders Netherlands 14 240 0.7× 328 1.3× 133 0.9× 109 0.8× 61 0.5× 20 877
Guangxi Zhou China 16 473 1.5× 420 1.7× 143 0.9× 118 0.9× 134 1.0× 54 1.0k
Janina Wolf Germany 14 382 1.2× 482 1.9× 320 2.1× 59 0.5× 139 1.1× 15 1.2k
Jyoti Patel United Kingdom 18 271 0.8× 300 1.2× 98 0.6× 176 1.4× 61 0.5× 33 953
Wen Qiu China 21 423 1.3× 412 1.6× 216 1.4× 47 0.4× 71 0.6× 64 1.2k

Countries citing papers authored by Jill Reckless

Since Specialization
Citations

This map shows the geographic impact of Jill Reckless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Reckless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Reckless more than expected).

Fields of papers citing papers by Jill Reckless

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Reckless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Reckless. The network helps show where Jill Reckless may publish in the future.

Co-authorship network of co-authors of Jill Reckless

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Reckless. A scholar is included among the top collaborators of Jill Reckless based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Reckless. Jill Reckless is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huntington, James A., et al.. (2025). The preclinical profile of SerpinPC: a potential new treatment for hemophilia. Blood Advances. 9(10). 2402–2409.
2.
3.
Azorín, Daniel Domínguez, Sophie Weil, Dirk C. Hoffmann, et al.. (2023). Abstract 1084: AI-aided drug development for disconnecting glioma tumor microtube networks. Cancer Research. 83(7_Supplement). 1084–1084. 1 indexed citations
4.
Salmon, Richard M., Jingxu Guo, Zhen Tong, et al.. (2020). Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms. Nature Communications. 11(1). 1621–1621. 53 indexed citations
5.
Roberts, Kevin J., Luana Maggiore, Keith P. Ray, et al.. (2019). Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients. Scientific Reports. 9(1). 14042–14042. 28 indexed citations
6.
Crowe, Jenny, Kevin J. Roberts, Luana Maggiore, et al.. (2018). Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. Scientific Reports. 8(1). 4941–4941. 48 indexed citations
7.
Wheeler, Daniel W., Andrew J. Thompson, Federico Corletto, et al.. (2011). Anaesthetic Impairment of Immune Function Is Mediated via GABAA Receptors. PLoS ONE. 6(2). e17152–e17152. 57 indexed citations
8.
Fox, David J., Jill Reckless, Hannah Lingard, Stuart Warren, & David J. Grainger. (2009). Highly Potent, Orally Available Anti-inflammatory Broad-Spectrum Chemokine Inhibitors. Journal of Medicinal Chemistry. 52(11). 3591–3595. 23 indexed citations
9.
Beech, John S., Daniel W. Wheeler, Jill Reckless, et al.. (2007). The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro. Journal of Neuroimmunology. 184(1-2). 198–208. 11 indexed citations
10.
Grainger, David W., Jill Reckless, & David A. Fox. (2005). Broad Spectrum Chemokine Inhibitors Related to NR58-3.14.3. Mini-Reviews in Medicinal Chemistry. 5(9). 825–832. 5 indexed citations
11.
Reckless, Jill, et al.. (2005). Broad-Spectrum Chemokine Inhibition Reduces Vascular Macrophage Accumulation and Collagenolysis Consistent with Plaque Stabilization in Mice. Journal of Vascular Research. 42(6). 492–502. 12 indexed citations
12.
Grainger, David J., Jill Reckless, & Elaine McKilligin. (2004). Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice. The Journal of Immunology. 173(10). 6366–6375. 151 indexed citations
13.
Frow, Emma, Jill Reckless, & David J. Grainger. (2004). Tools for anti‐inflammatory drug design: In vitro models of leukocyte migration. Medicinal Research Reviews. 24(3). 276–298. 25 indexed citations
14.
Grainger, David J. & Jill Reckless. (2003). Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo. Biochemical Pharmacology. 65(7). 1027–1034. 30 indexed citations
15.
Reckless, Jill, et al.. (2001). A Common Phenotype Associated with Atherogenesis in Diverse Mouse Models of Vascular Lipid Lesions. Journal of Vascular Research. 38(3). 256–265. 13 indexed citations
16.
17.
Fox, David J., Jill Reckless, Stuart Warren, & David J. Grainger. (2001). Design, Synthesis, and Preliminary Pharmacological Evaluation of N-Acyl-3-aminoglutarimides as Broad-Spectrum Chemokine Inhibitors in Vitro and Anti-inflammatory Agents in Vivo. Journal of Medicinal Chemistry. 45(2). 360–370. 16 indexed citations
18.
Grainger, David J., Jill Reckless, James C. Metcalfe, Edward M. Rubin, & Richard Lawn. (1997). 1.W08.1 Lp(a) and endothelium: A feedback loop in atherosclerosis. Atherosclerosis. 134(1-2). 15–15. 2 indexed citations
19.
Lawn, Richard M., Andrew D. Pearle, Edward M. Rubin, et al.. (1996). Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice. Journal of Biological Chemistry. 271(49). 31367–31371. 50 indexed citations
20.
Reckless, Jill, et al.. (1994). Changes in the caldesmon isoform content and intimal thickening in the rabbit carotid artery induced by a silicone elastomer collar.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(11). 1837–1845. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Gerwien Breakdown of academic impact, for papers by Cornelius A. Watson Breakdown of academic impact, for papers by Dennis H. M. Kusters Breakdown of academic impact, for papers by Mineko Tsuruoka Breakdown of academic impact, for papers by Kazuyoshi Watanabe Breakdown of academic impact, for papers by M. Sanders Breakdown of academic impact, for papers by Guangxi Zhou Breakdown of academic impact, for papers by Janina Wolf Breakdown of academic impact, for papers by Jyoti Patel Breakdown of academic impact, for papers by Wen Qiu
Rankless by CCL
2026